Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6913374 | 0.98 | ALDH1A1 (0.31) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL2524574 | 0.77 | — | — | |
| SCHEMBL3719747 | 0.76 | ALDH1A1 (0.34) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL32675817 | 0.75 | TSHR (0.32) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL4239001 | 0.75 | — | — | |
| SCHEMBL2023512 | 0.73 | — | — | |
| SCHEMBL2216342 | 0.73 | ALDH1A1 (0.32) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Ethylene Glycol SCHEMBL413417 | 0.72 | ALDH1A1 (0.31) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| Ethylene Glycol SCHEMBL10584826 | 0.72 | ALDH1A1 (0.31) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL6847342 | 0.69 | MEN1 (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116744984-A | Reactive dry powder hemostatic material comprising protein and a multi-functionally modified polyethylene glycol-based crosslinker | 达沃有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-114025706-A | Reactive dry powder hemostatic material comprising a nucleophile and a multifunctional modified polyethylene glycol-based cross-linker | 达沃有限公司 | 2022-02-08 | — | — | CN | claimed |
| EP-2939697-B1 | HEMOSTATIC SPONGE | BAXTER INT (US) | 2016-08-31 | — | — | EP | claimed |
| EP-1687041-A2 | SOFT TISSUE IMPLANTS AND ANTI-SCARRING AGENTS | Angiotech International AG (CH) | 2006-08-09 | — | — | EP | claimed |
| WO-2005051444-A2 | SOFT TISSUE IMPLANTS AND ANTI-SCARRING AGENTS | ANGIOTECH INTERNATIONAL AG (CH) | 2005-06-09 | — | — | WO | claimed |
| US-20240002549-A1 | REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT | DAVOL INC. (US) | 2024-01-04 | — | — | US | disclosed |
| EP-4267210-A1 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | Davol Inc. (US) | 2023-11-01 | — | — | EP | disclosed |
| CN-116744984-A | Reactive dry powder hemostatic material comprising protein and a multi-functionally modified polyethylene glycol-based crosslinker | 达沃有限公司 | 2023-09-12 | — | — | CN | disclosed |
| US-11739166-B2 | Reactive polysaccharide-based hemostatic agent | DAVOL INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-20220211900-A1 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | DAVOL INC. (US) | 2022-07-07 | — | — | US | disclosed |
| WO-2022146917-A1 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | DAVOL INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| EP-3989875-A1 | REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A NUCLEOPHILE AND A MULTIFUNCTIONAL MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT | Davol Inc. (US) | 2022-05-04 | — | — | EP | disclosed |
| EP-2049076-A1 | METHOD FOR MAKING UP OR CARING FOR KERATINOUS SUBSTANCES WITH NONCROSSLINKED POLYROTAXANES | L'Oreal (FR) | 2009-04-22 | — | — | EP | disclosed |
| US-20090028957-A1 | Implantable Tissue-Reactive Biomaterial Compositions and Systems, and Methods of Us Thereof | DANILOFF GEORGE Y | 2009-01-29 | — | — | US | disclosed |
| WO-2008015272-A1 | METHOD FOR MAKING UP OR CARING FOR KERATINOUS SUBSTANCES WITH NONCROSSLINKED POLYROTAXANES | L'OREAL (FR) | 2008-02-07 | — | — | WO | disclosed |
| WO-2006121518-A2 | ELECTRICAL DEVICES, ANTI-SCARRING AGENTS, AND THERAPEUTIC COMPOSITIONS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-11-16 | — | — | WO | disclosed |
| WO-2006113845-A1 | IMPLANTABLE TISSUE-REACTIVE BIOMATERIAL COMPOSITIONS AND SYSTEMS, AND METHODS OF USE THEREOF | THERABIT, INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006034467-A2 | BIOCOMPATIBLE HYDROGEL COMPOSITIONS | JULIAZ INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2005051232-A2 | SOFT TISSUE IMPLANTS AND ANTI-SCARRING AGENTS | ANGIOTECH INTERNATIONAL AG (CH) | 2005-06-09 | — | — | WO | disclosed |
| US-20050054771-A1 | Adhesive tissue repair patch | ANGIOTECH AMERICA, INC. (CA) | 2005-03-10 | — | — | US | disclosed |